Our experimental data demonstrate that Germacrone has a significant hepatoprotective effects against ALD by regulating the Nrf2/Rbp4 signaling pathway to improve liver lipid metabolism disorders and oxidative stress damage. Here, RBP4 is linked to digestive system neoplasm.